1381849-06-4

Upstream product

• 134098-64-9 2‐{3‐[(O‐tert‐butyldimethylsilyl)hydroxy]‐1,1‐dimethylpropyl}‐3,5‐dimethylphenol 
• 103-40-2 succinic acid monobenzyl ester 
• 1381849-03-1 benzyl 2-(4-hydroxy-2-methylbutan-2-yl)-3,5-dimethylphenyl succinate 
• 1281884-94-3 benzyl 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate 
• 1381849-05-3 3-(2-(4-(benzyloxy)-4-oxobutanoyloxy)-4,6-dimethylphenyl)-3-methylbutanoic acid 

Downstream Products

• 1381849-07-5 C₃₄H₃₈FN₃O₈ 
• 1381849-08-6 C₅₉H₈₄FN₉O₁₅ 

Relevant academic research and scientific papers

Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers

Two desferrioxamine B-ciprofloxacin conjugates with 'trimethyl-lock' based linkers that are designed to release the antibiotic after esterase or phosphatase-mediated hydrolysis were synthesized. The potential esterase-sensitive conjugate 13 displayed mode